JP2012508575A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012508575A5 JP2012508575A5 JP2011536276A JP2011536276A JP2012508575A5 JP 2012508575 A5 JP2012508575 A5 JP 2012508575A5 JP 2011536276 A JP2011536276 A JP 2011536276A JP 2011536276 A JP2011536276 A JP 2011536276A JP 2012508575 A5 JP2012508575 A5 JP 2012508575A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- natural killer
- cell population
- pharmaceutical composition
- foxp3
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11436208P | 2008-11-13 | 2008-11-13 | |
| US61/114,362 | 2008-11-13 | ||
| PT10476409 | 2009-09-25 | ||
| PT104764 | 2009-09-25 | ||
| PCT/PT2009/000060 WO2010056144A2 (en) | 2008-11-13 | 2009-11-13 | Foxp3+ natural kiler t-cells and the treatment of immune related diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012508575A JP2012508575A (ja) | 2012-04-12 |
| JP2012508575A5 true JP2012508575A5 (https=) | 2013-01-17 |
Family
ID=42138978
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011536276A Pending JP2012508575A (ja) | 2008-11-13 | 2009-11-13 | Ｆｏｘｐ３＋ナチュラルキラーＴ細胞および免疫関連疾患の治療方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20120114675A1 (https=) |
| EP (1) | EP2356222A2 (https=) |
| JP (1) | JP2012508575A (https=) |
| CN (1) | CN102216448A (https=) |
| AU (1) | AU2009314704A1 (https=) |
| BR (1) | BRPI0915255A2 (https=) |
| CA (1) | CA2743502A1 (https=) |
| WO (1) | WO2010056144A2 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102603892B (zh) * | 2012-02-22 | 2013-10-30 | 尉军 | 一种肿瘤标志物foxp3抗原多肽及应用 |
| AU2015228372B2 (en) * | 2014-03-12 | 2018-05-31 | Yeda Research And Development Co. Ltd | Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNS |
| AU2015273501B2 (en) * | 2014-06-11 | 2021-01-21 | Polybiocept Gmbh | Expansion of lymphocytes with a cytokine composition for active cellular immunotherapy |
| TWI702290B (zh) * | 2015-04-07 | 2020-08-21 | 富禾生醫股份有限公司 | 經修飾之自然殺手ｔ細胞、醫藥組合物及其用途 |
| CN105039255A (zh) * | 2015-09-09 | 2015-11-11 | 广州赛莱拉干细胞科技股份有限公司 | 一种nkt细胞诱导培养的添加剂及诱导培养的方法 |
| CN107475194B (zh) * | 2017-10-09 | 2018-07-24 | 天津长和生物技术有限公司 | Nkt细胞培养基、培养方法及二者的应用 |
| US20220184172A1 (en) * | 2019-04-19 | 2022-06-16 | The Regents Of The University Of California | Ampk/caspase-6 axis controls liver damage in nonalcoholic steatohepatitis |
| US12365871B2 (en) | 2020-04-28 | 2025-07-22 | Lyell Immunopharma, Inc. | Methods for culturing cells |
| WO2025221808A1 (en) * | 2024-04-15 | 2025-10-23 | Trustees Of Tufts College | Efficient epigenetic reprogramming of t effector cells into stable regulatory t cells |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU643141B2 (en) | 1991-03-15 | 1993-11-04 | Amgen, Inc. | Pulmonary administration of granulocyte colony stimulating factor |
| US5451569A (en) | 1994-04-19 | 1995-09-19 | Hong Kong University Of Science And Technology R & D Corporation Limited | Pulmonary drug delivery system |
| DE60141510D1 (de) * | 2000-04-11 | 2010-04-22 | Univ Southern California | Methode zur verhinderung der transplantatabstossung unter verwendung von tgf-beta zur induktion von t-suppressorzellen |
| JP4989850B2 (ja) * | 2002-10-25 | 2012-08-01 | アメリカ合衆国 | ＴＧＦ−βの遮断により腫瘍再発を防ぐ方法 |
-
2009
- 2009-11-13 WO PCT/PT2009/000060 patent/WO2010056144A2/en not_active Ceased
- 2009-11-13 US US13/129,146 patent/US20120114675A1/en not_active Abandoned
- 2009-11-13 AU AU2009314704A patent/AU2009314704A1/en not_active Abandoned
- 2009-11-13 CA CA2743502A patent/CA2743502A1/en not_active Abandoned
- 2009-11-13 CN CN2009801452249A patent/CN102216448A/zh active Pending
- 2009-11-13 EP EP09764330A patent/EP2356222A2/en not_active Withdrawn
- 2009-11-13 JP JP2011536276A patent/JP2012508575A/ja active Pending
- 2009-11-13 BR BRPI0915255A patent/BRPI0915255A2/pt not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012508575A5 (https=) | ||
| Pieren et al. | The adaptive immune system in early life: The shift makes it count | |
| Lang et al. | How important is vitamin D in preventing infections? | |
| Fina et al. | Regulation of gut inflammation and th17 cell response by interleukin-21 | |
| Heiseke et al. | CCL17 promotes intestinal inflammation in mice and counteracts regulatory T cell–mediated protection from colitis | |
| Sarra et al. | Il-23/Il-17 Axis in IBD | |
| Schnupf et al. | Segmented filamentous bacteria, Th17 inducers and helpers in a hostile world | |
| Huang et al. | The broad immunomodulatory effects of IL-7 and its application in vaccines | |
| CN102271702B (zh) | 抗第三方中枢记忆性t细胞、产生其的方法及其在移植和疾病治疗中的用途 | |
| Wang et al. | Nlrp3 inflammasome drives regulatory T cell depletion to accelerate periapical bone erosion | |
| Ahlberg et al. | Innate immune responses induced by the saponin adjuvant Matrix-M in specific pathogen free pigs | |
| Lozano‐Ojalvo et al. | Oral immunotherapy with egg peptides induces innate and adaptive tolerogenic responses | |
| Schrum et al. | Bacterial infection induces expression of functional MHC class II molecules in murine and human osteoblasts | |
| JP2008534620A (ja) | 制御性ｔ細胞を用いた移植組織の拒絶反応の防止 | |
| Lin et al. | The co-administrating of recombinant porcine IL-2 could enhance protective immune responses to PRV inactivated vaccine in pigs | |
| ES2731849T3 (es) | Composiciones para la inducción específica de antígeno de inmunotolerancia mediante inmunización oral | |
| Zhao et al. | Mesenteric CD103+ DCs initiate switched coxsackievirus B3 VP1-specific IgA response to intranasal chitosan-DNA vaccine through secreting BAFF/IL-6 and promoting Th17/Tfh differentiation | |
| Sakthivel et al. | CCL5 regulation of mucosal chlamydial immunity and infection | |
| Rynda‐Apple et al. | Active immunization using a single dose immunotherapeutic abates established EAE via IL‐10 and regulatory T cells | |
| JP2020535832A5 (https=) | ||
| JP2005537236A (ja) | プロバイオティック治療 | |
| Hattori et al. | Intranasal application of purified protein derivative suppresses the initiation but not the exacerbation of allergic rhinitis in mice | |
| Sahay et al. | Activation of B cells by a dendritic cell-targeted oral vaccine | |
| CN1443075A (zh) | 用于治疗念珠菌病的组合物和方法 | |
| Olivares-Villagómez et al. | Intestinal epithelial cells modulate CD4 T cell responses via the thymus leukemia antigen |